Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Revenue (2019 - 2025)

Volitionrx filings provide 8 years of Revenue readings, the most recent being -$3771.0 for Q4 2025.

  • On a quarterly basis, Revenue rose 89.66% to -$3771.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 26.76% increase, with the full-year FY2025 number at $1.3 million, up 26.98% from a year prior.
  • Revenue hit -$3771.0 in Q4 2025 for Volitionrx, down from $538381.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $538381.0 in Q3 2025 to a low of -$36481.0 in Q4 2024.
  • Median Revenue over the past 5 years was $134761.5 (2022), compared with a mean of $164817.6.
  • Biggest five-year swings in Revenue: soared 8298.03% in 2021 and later plummeted 114.95% in 2024.
  • Volitionrx's Revenue stood at $14240.0 in 2021, then surged by 740.7% to $119715.0 in 2022, then surged by 103.79% to $243973.0 in 2023, then plummeted by 114.95% to -$36481.0 in 2024, then surged by 89.66% to -$3771.0 in 2025.
  • The last three reported values for Revenue were -$3771.0 (Q4 2025), $538381.0 (Q3 2025), and $406688.0 (Q2 2025) per Business Quant data.